Antibodies from Sinovac's Covid-19 shot fade after about 6 months, booster helps: study

Published July 26, 2021
The study was conducted by researchers at disease control authorities in Jiangsu province, Sinovac, and other Chinese institutions. — AFP/File
The study was conducted by researchers at disease control authorities in Jiangsu province, Sinovac, and other Chinese institutions. — AFP/File

Antibodies triggered by Sinovac Biotech's Covid-19 vaccine decline below a key threshold from around six months after a second dose for most recipients, although a third shot could have a strong boosting effect, according to a lab study.

Chinese researchers reported the findings from a study of blood samples from healthy adults aged between 18-59 in a paper published on Sunday, which has not been peer reviewed.

For participants receiving two doses, two or four weeks apart, only 16.9 per cent and 35.2pc, respectively, still had a level of neutralising antibodies above the threshold six months after the second dose, the paper said.

Those readings were based on data from two cohorts involving more than 50 participants each, while the study gave third doses to a total of 540 participants.

When participants in some cohorts were given a third dose, about six months after the second, neutralising antibody levels after a further 28 days had increased around 3-5 fold from the levels seen four weeks after the second dose, the study showed.

The study was conducted by researchers at disease control authorities in Jiangsu province, Sinovac, and other Chinese institutions.

Researchers cautioned the study did not test the antibodies' effect against more transmissible variants, and that further research was needed to assess antibody duration after a third shot.

Last month, Sinovac spokesman Liu Peicheng told Reuters preliminary results from blood samples of the vaccinated showed a three-fold reduction in neutralising effect against the Delta variant and suggested a third Sinovac shot could elicit more durable antibody reaction.

Earlier this month, Thailand announced it would use AstraZeneca's Covid-19 vaccine as a second dose for those who received Sinovac's shot as their first dose in a bid to increase protection.

The move was the first publicly announced mix-and-match of a Chinese vaccine and a Western-developed shot, as a new preliminary Thai study raised doubts about the longer-term protection of the two-dose Sinovac vaccine.

The announcement came after Thailand's health ministry said 618 medical workers out of 677,348 personnel who received two doses of the Sinovac vaccine became infected from April to July. One nurse died.

Neighbouring Indonesia has also reported breakthrough infections among medical and frontline workers who are fully inoculated with the Sinovac vaccine.

Opinion

Sub judice rule
18 Sep 2021

Sub judice rule

It is time this objection, sub judice, is laid to rest.
The Black Caps folly
Updated 18 Sep 2021

The Black Caps folly

There is so much wrong — and worrying — about the entire sorry episode of New Zealand backing out of Pakistan tour.
CT NAP revisited
Updated 18 Sep 2021

CT NAP revisited

A policy of appeasement towards extremists has undermined the state’s writ.
Pathways for reform
Updated 17 Sep 2021

Pathways for reform

Even now the government has said they are listening, but they have not said how they are listening.

Editorial

Blinken’s remarks
Updated 18 Sep 2021

Blinken’s remarks

The US establishment cannot scapegoat Pakistan for two decades of bad policy in Afghanistan.
18 Sep 2021

Worrying survey

THE findings of the Labour Force Survey 2018-19 indicate that some important headline trends have already taken or...
18 Sep 2021

Special needs

THE fact that only 3,653 children with special needs, out of some 300,000 in Sindh, are registered with the...
TTP amnesty?
Updated 17 Sep 2021

TTP amnesty?

An amnesty should be for some individuals, not the entire outfit.
17 Sep 2021

Media regulation

THE needless controversy over media regulation may finally be heading for a resolution. In a meeting with ...
17 Sep 2021

Refusing audit

THE continuous resistance put up by several public-sector organisations to submitting their accounts for audit by ...